Lafutidine, 99%

Name: Lafutidine, 99% | 118288-08-7
Brand: J&K Chemical
SKU: JK356680_250_MG
Price: 600.0 USD
Availability: OutOfStock

Cat. No JK356680_250_MG

Vendor: J&K Chemical

Product Information

Product Name

Lafutidine, 99%

Brand Name

J&K

Product Number

356680

CAS

118288-08-7

Molecular Formula

C22H29N3O4S

Molecular Weight

431.55

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

(Z)-2-((Furan-2-ylmethyl)sulfinyl)-N-(4-((3-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide

PubChem CID

5282136

IUPAC Name

2-(furan-2-ylmethylsulfinyl)-N-(Z)-4-4-(piperidin-1-ylmethyl)-2-pyridinyloxybut-2-enylacetamide

InChI Key

KMZQAVXSMUKBPD-DJWKRKHSSA-N

SMILES

C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3

Safety Information

Precautionary Statement

P262

References Data Source From Pubchem

Optimization and Characterization of Lafutidine Liquisolid Pellets: A Novel Strategy for Improved Solubility and Drug Release

Publication Name: BioNanoScience

Publication Date: 2026-02-16

DOI: 10.1007/s12668-025-02394-4

Fabrication of Curcumin and Voriconazole-Loaded Nanosponges Hydrogel for Topical Treatment of Candida albicans: In Vitro, Ex Vivo, and In Vivo Assessments

Publication Name: Journal of Pharmaceutical Innovation

Publication Date: 2026-02-06

DOI: 10.1007/s12247-025-10365-1

In Situ Gellable Hydrogels for Gastroretentive Drug Delivery Systems

Publication Name: In Situ Gellable Hydrogels for Drug Delivery and Tissue Engineering

Publication Date: 2026

DOI: 10.1007/978-981-95-6619-8_4

The use of antihistamine and antihistamine-like drugs for cancer-related pain: a narrative review

Publication Name: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Publication Date: 2025-11-22

DOI: 10.1007/s00520-025-10158-9

Quality by design approach for optimization, in-vitro and in-vivo evaluation of compression-spheronized itopride hydrochloride loaded gastroretentive pellets for the treatment of gastroesophageal reflux disease

Publication Name: Naunyn-Schmiedeberg's Archives of Pharmacology

Publication Date: 2025-10-18

DOI: 10.1007/s00210-025-04728-1

Lafutidine, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Optimization and Characterization of Lafutidine Liquisolid Pellets: A Novel Strategy for Improved Solubility and Drug Release

Fabrication of Curcumin and Voriconazole-Loaded Nanosponges Hydrogel for Topical Treatment of Candida albicans: In Vitro, Ex Vivo, and In Vivo Assessments

In Situ Gellable Hydrogels for Gastroretentive Drug Delivery Systems

The use of antihistamine and antihistamine-like drugs for cancer-related pain: a narrative review

Quality by design approach for optimization, in-vitro and in-vivo evaluation of compression-spheronized itopride hydrochloride loaded gastroretentive pellets for the treatment of gastroesophageal reflux disease

Lafutidine, 99%

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Lafutidine, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Optimization and Characterization of Lafutidine Liquisolid Pellets: A Novel Strategy for Improved Solubility and Drug Release

Fabrication of Curcumin and Voriconazole-Loaded Nanosponges Hydrogel for Topical Treatment of Candida albicans: In Vitro, Ex Vivo, and In Vivo Assessments

In Situ Gellable Hydrogels for Gastroretentive Drug Delivery Systems

The use of antihistamine and antihistamine-like drugs for cancer-related pain: a narrative review

Quality by design approach for optimization, in-vitro and in-vivo evaluation of compression-spheronized itopride hydrochloride loaded gastroretentive pellets for the treatment of gastroesophageal reflux disease

Lafutidine, 99%

Related Product

#title#

Login

Register